|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 7.820 USD | -0.26% |
|
+28.41% | -44.89% |
| 09-03 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| Market Cap | 35.79M 30.8M 28.98M 26.47M 49.52M 3.38B 49.66M 342M 133M 1.73B 134M 131M 5.59B | P/E 2026 * |
-1.23x | P/E 2027 * | -1.33x |
|---|---|---|---|---|---|
| Enterprise Value | 35.79M 30.8M 28.98M 26.47M 49.52M 3.38B 49.66M 342M 133M 1.73B 134M 131M 5.59B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.36% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NXTC | Delayed | |
CBOE
| NXTC | Real-time |
Last Transcript : NextCure, Inc.
| 1 day | -0.26% | ||
| 1 week | +28.41% | ||
| Current month | +22.38% | ||
| 1 month | +48.95% | ||
| 3 months | +165.08% | ||
| 6 months | -38.71% | ||
| Current year | -44.89% |
| 1 week | 6.08 |  | 8.3 |
| 1 month | 5.15 | | 8.72 |
| Current year | 1.55 | | 14.65 |
| 1 year | 1.55 | | 15.74 |
| 3 years | 1.55 | | 30.84 |
| 5 years | 1.55 | | 110.16 |
| 10 years | 1.55 | | 1,308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Richman
CEO | Chief Executive Officer | 65 | 2015-11-30 |
Steven Cobourn
DFI | Director of Finance/CFO | 63 | 2017-12-31 |
Udayan Guha
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Richman
BRD | Director/Board Member | 65 | 2015-11-30 |
Elaine Jones
BRD | Director/Board Member | 71 | 2015-11-30 |
David Kabakoff
CHM | Chairman | 78 | 2015-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/10/26 | Sell | Company | -30,000 | 0.6554% | ||
| 7/31/26 | Adar1 Capital Management LLC
| Buy | Company | 36,303 | 0.7931% | |
| 7/29/26 | Adar1 Capital Management LLC
| Buy | Company | 3,410 | 0.0944% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | +28.41% | +61.24% | -54.43% | 35.79M | |
| -1.79% | -2.27% | +43.23% | +88.96% | 67.98B | |
| -2.06% | -0.18% | +39.67% | +86.44% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +378.92% | 27.58B | |
| -3.00% | -2.90% | +33.13% | +12.54% | 25.74B | |
| +0.86% | +1.65% | -7.74% | -14.95% | 26.06B | |
| -1.46% | +0.42% | +23.61% | -18.61% | 20.09B | |
| -2.96% | -15.21% | +216.20% | +368.10% | 17.16B | |
| -1.49% | -4.88% | -6.60% | +531.89% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +164.98% | 14.62B | |
| Average | -1.27% | +3.07% | +44.56% | +154.38% | 27.91B | |
| Weighted average by Cap. | -1.52% | +0.18% | +38.38% | +137.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -33.8M -29.08M -27.36M -25M -46.76M -3.19B -46.89M -323M -125M -1.64B -127M -124M -5.27B | -43.65M -37.56M -35.34M -32.28M -60.39M -4.12B -60.56M -418M -162M -2.11B -164M -160M -6.81B |
| Net Debt | - | - |
Employees
40
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$7.820 | -0.26% | 60,631 |
| 26-09-03 | US$7.840 | +6.67% | 161,561 |
| 26-09-02 | US$7.350 | +8.09% | 112,640 |
| 26-09-01 | US$6.800 | +6.42% | 112,895 |
| 26-08-31 | US$6.390 | +4.93% | 54,889 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.820USD
Average target price
20.00USD
Spread / Average Target
+155.75%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXTC Stock
Select your edition
All financial news and data tailored to specific country editions
